Metabolic regulation of Sirtuins upon fasting and the implication for cancer.

Abstract:

PURPOSE OF REVIEW:The purpose of this review is to highlight recent studies on mammalian sirtuins that coordinately regulate cellular metabolic homeostasis upon fasting and to summarize the beneficial effects of fasting on carcinogenesis and cancer therapy. RECENT FINDINGS:Recent studies have demonstrated that fasting may protect normal cells and mice from the metabolic conditions that are harmful as well as decrease the incidence of carcinogenesis. Fasting could also slow the tumor growth and augment the efficacy of certain systemic agents/chemotherapy drugs in various cancers. The mechanism behind this proposed idea may be due to, at least in some part, the metabolic regulation by Sirtuin family proteins whose functions are involved in specific aspects of longevity, stress response and metabolism. Sirtuins, particularly SIRT1 and SIRT3, can be activated by fasting and further exhibit their effects in insulin response, antioxidant defense, and glycolysis. Therefore, sirtuins may have anticancer effects by shifting metabolism to a less proliferative cell phenotype as well as less prone to oxidative stress attack. SUMMARY:The in-depth understanding of the essential role of sirtuins in fasting process may have significant implications in developing a new metabolic diagram of cancer prevention or treatment.

journal_name

Curr Opin Oncol

authors

Zhu Y,Yan Y,Gius DR,Vassilopoulos A

doi

10.1097/01.cco.0000432527.49984.a3

subject

Has Abstract

pub_date

2013-11-01 00:00:00

pages

630-6

issue

6

eissn

1040-8746

issn

1531-703X

journal_volume

25

pub_type

杂志文章,评审
  • The changing face of invasive fungal infections in hematopoietic cell transplant recipients.

    abstract:PURPOSE OF REVIEW:To review recent observations that describe changes in the likelihood of invasive fungal infections, shifts in types of fungal pathogens, and altered manifestations of fungal syndromes after hematopoietic cell transplantation and explore how changes in transplant practices are influencing these epidem...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000152975.65477.7c

    authors: Wingard JR

    更新日期:2005-03-01 00:00:00

  • Environmental estrogens and breast cancer risk.

    abstract::Controversy exists over the role that environmental estrogens, such as pesticides or polychlorinated biphenyls (PCBs), might play as risk factors for breast cancer. Several laboratory studies have suggested that these chemicals function as weak estrogens, binding to the estrogen receptor and inducing various measures ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199809000-00018

    authors: Davidson NE

    更新日期:1998-09-01 00:00:00

  • What is new in the management of salivary gland cancers?

    abstract:PURPOSE OF REVIEW:Salivary gland malignancies are a rare and heterogeneous group of tumors with considerable variability in their natural history. Historically they have been treated with surgery and radiation therapy. It is only recently that there has been any growth in our understanding of these diseases and their m...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328344f59c

    authors: Adelstein DJ,Rodriguez CP

    更新日期:2011-05-01 00:00:00

  • Advances in the biology and treatment of multiple myeloma.

    abstract::Advances in the understanding of the cellular and molecular derangements involved in the initiation and progression of multiple myeloma are beginning to be translated into novel therapeutic approaches. The myeloma stem cell has been under intense scrutiny regarding its normal B-cell counterpart. Oncogenes, tumor-suppr...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199901000-00002

    authors: Varterasian ML

    更新日期:1999-01-01 00:00:00

  • Gene transfer technologies for malignant gliomas.

    abstract::Although early clinical gene therapy trials for recurrent central nervous system neoplasms showed the proof-of-principle, they did not fulfill the high expectations suggested by the preclinical experimental data. Insufficient distribution of vectors in human brain tumors and very low transduction efficiency require th...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199905000-00005

    authors: Weyerbrock A,Oldfield EH

    更新日期:1999-05-01 00:00:00

  • Renal cell carcinoma.

    abstract:PURPOSE OF REVIEW:The recent contributions to renal cell carcinoma in the fields of molecular biology and the expanded use of molecularly targeted agents will be reviewed. This study is intended to update prognostic and therapeutic decision-making data and provide perspective on advances in understanding the molecular ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3282f9782b

    authors: Rini BI,Rathmell WK,Godley P

    更新日期:2008-05-01 00:00:00

  • High-dose therapy with autologous bone marrow transplantation for the treatment of solid tumors.

    abstract::Over the past decade, high-dose chemotherapy followed by autologous bone marrow support (ABMS) has been employed with increasing frequency to treat patients with a variety of solid tumors. This paper explores the rationale and relevant clinical data for the use of this approach to treat patients with breast and ovaria...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199403000-00004

    authors: Shpall EJ,Jones RB,Bearman S

    更新日期:1994-03-01 00:00:00

  • Approaches to relapse after allogeneic stem cell transplantation.

    abstract:PURPOSE OF REVIEW:Relapse has become the leading cause of death following allogeneic hematopoietic stem cell transplantation (HSCT). Despite improved understanding of the biology that underlies the graft-versus-leukemia/tumor effect the relapse rate did not decrease over the past 20 years. In general, prognosis is poor...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e328342c6c8

    authors: Kröger N

    更新日期:2011-03-01 00:00:00

  • Bone marrow transplantation for chronic myelogenous leukemia.

    abstract::It is generally accepted that patients with chronic myelogenous leukemia in chronic phase under the age of 50 years who have HLA-identical siblings, should be offered bone marrow transplantation within the first year of diagnosis. The projected disease-free survival for these patients is 70% to 80% at 4 years, and mos...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199204000-00004

    authors: Goldman JM

    更新日期:1992-04-01 00:00:00

  • Recent advances in telomere biology: implications for human cancer.

    abstract:PURPOSE OF REVIEW:Research into the basic biology of telomeres continues to reveal details relevant to fundamental aspects of human cancer. The goal of this review is to highlight discoveries made within the last year, with emphasis on their relevance to cancer prevention, diagnosis, prognostics, and treatment. RECENT...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200401000-00007

    authors: Meeker AK,De Marzo AM

    更新日期:2004-01-01 00:00:00

  • The type II transforming growth factor-beta receptor as a tumor-suppressor gene.

    abstract::Recent work has shown that: 1) loss of transforming growth factor-beta response is associated with malignant progression, 2) maintenance of autocrine negative transforming growth factor-beta activity is a key impediment to malignant progression, and 3) the major mechanism for loss of RII expression in replication erro...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199601000-00009

    authors: Brattain MG,Markowitz SD,Willson JK

    更新日期:1996-01-01 00:00:00

  • Single-cell sequencing in hematology.

    abstract:PURPOSE OF REVIEW:In this review, we highlight key recent insights into hematopoiesis and hematological malignancies through the application of novel single-cell approaches. We particularly focus on biological insights made through the study of stem/progenitors cells in myeloid malignancy at single-cell resolution. RE...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000613

    authors: Brierley CK,Mead AJ

    更新日期:2020-03-01 00:00:00

  • Neuroendocrine tumors of the diffuse neuroendocrine system.

    abstract:PURPOSE OF REVIEW:Neuroendocrine tumors (previously referred to as carcinoids) are ill-understood, enigmatic malignancies that, although slow-growing compared with adenocarcinomas, can behave aggressively. In 2004, they comprised 1.25% of all malignancies; their incidence is increasing by approximately 6% per year. The...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3282f1c595

    authors: Gustafsson BI,Kidd M,Modlin IM

    更新日期:2008-01-01 00:00:00

  • Thyroid nodules: diagnosis and therapy.

    abstract::Less than 1% of all cancers are present in the thyroid, yet thyroid nodules are found in 4 to 10% of the adult population. Because thyroid nodules are relatively common, the diagnostic dilemma is to distinguish between a more common benign nodule, which usually does not require specific treatment, and a malignant nodu...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200201000-00009

    authors: Weiss RE,Lado-Abeal J

    更新日期:2002-01-01 00:00:00

  • Adjuvant therapy for melanoma.

    abstract::The search for effective adjuvant therapy for melanoma has resulted in the testing of a remarkably broad spectrum of therapeutic agents. Until recently, there was little evidence to suggest a benefit for any adjuvant therapy. The demonstration of activity for adjuvant high-dose interferon alfa in a cooperative group t...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199703000-00015

    authors: Sondak VK,Wolfe JA

    更新日期:1997-03-01 00:00:00

  • Prostate-specific membrane antigen positron emission tomography in prostate cancer: a step toward personalized medicine.

    abstract:PURPOSE OF REVIEW:Increasing attention is being given to personalized medicine in oncology, where therapies are tailored to the particular characteristics of the individual cancer patient. In recent years, there has been greater focus on prostate-specific membrane antigen (PSMA) in prostate cancer (PCa) as a target for...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000277

    authors: Bouchelouche K,Choyke PL

    更新日期:2016-05-01 00:00:00

  • Late sequelae of treatment of Hodgkin's disease.

    abstract::Twenty-three years after it was observed that successful treatment of Hodgkin's disease was associated with risk of a second malignancy related to treatment, the literature is maturing. Early reports of leukemia risk rising and falling between 5 and 10 years after treatment continue to be supported. The real problem i...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章

    doi:10.1097/00001622-199709050-00006

    authors: DeVita VT Jr

    更新日期:1997-09-01 00:00:00

  • Bisphosphonates in cancer therapy.

    abstract::Bisphosphonates inhibit osteoclast-mediated bone resorption in metastatic bone disease. A wealth of preclinical data have begun to shed light on the complex mechanisms by which bisphosphonates inhibit bone resorption and interfere with the formation and growth of bone metastases. Nitrogen-containing bisphosphonates in...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200211000-00004

    authors: Green JR

    更新日期:2002-11-01 00:00:00

  • Renal cell carcinoma.

    abstract::Renal cell carcinoma remains a challenge for oncologists, with only 20% of patients being cured by surgical removal of the involved kidney and a handful of patients with advanced disease being cured by surgery, immunotherapy, or both. Although advances in early detection, recognition of high-risk groups, and chemother...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199405000-00013

    authors: Savage PD

    更新日期:1994-05-01 00:00:00

  • Doxorubicin and multidrug resistance.

    abstract::The circumvention of P-glycoprotein function by pharmacologic agents is a major focus of clinical trials aimed at increasing the cytotoxicity of multidrug resistance-associated drugs, including doxorubicin. The success of this approach will likely depend on the clinical significance of P-glycoprotein expression, which...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-199311000-00014

    authors: Kruh GD,Goldstein LJ

    更新日期:1993-11-01 00:00:00

  • Epidemiology and etiology of leukemia.

    abstract::New clinical and epidemiologic studies provide information about the possible causes of human leukemia. Evidence for a viral etiology continues to appear, and the relationship between myelodysplastic syndrome and the leukemias is now linked through molecular genetic studies. Molecular mechanisms of leukemogenesis are ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Vogel VG,Fisher RE

    更新日期:1993-01-01 00:00:00

  • Myelodysplastic syndromes in children.

    abstract:PURPOSE OF REVIEW:Myelodysplastic syndromes (MDSs) are rare disorders in children, showing peculiar clinical manifestations and biological features. This review will summarize biological, genetic and clinical features of childhood MDS and will provide an update of the algorithm of treatment of the different disease var...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000488

    authors: Galaverna F,Ruggeri A,Locatelli F

    更新日期:2018-11-01 00:00:00

  • Cabozantinib as an emerging treatment for sarcoma.

    abstract:PURPOSE OF REVIEW:Sarcomas are a diverse group of rare solid tumors with limited treatment options for patients with advanced, inoperable disease. Cabozantinib is a tyrosine kinase inhibitor currently approved for advanced renal cell, hepatocellular, and medullary thyroid carcinoma. Cabozantinib has potent activity aga...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000644

    authors: Schöffski P,Blay JY,Ray-Coquard I

    更新日期:2020-07-01 00:00:00

  • Advances in prostate cancer.

    abstract:PURPOSE OF REVIEW:The purpose of this review is to highlight the most important developments in the diagnosis, prevention, and management of prostate cancer reported in the past year that have been published in the medical literature. RECENT FINDINGS:Recent research has yielded important insights into the effects of l...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200405000-00009

    authors: Ryan CJ,Small EJ

    更新日期:2004-05-01 00:00:00

  • Best supportive care versus palliative chemotherapy in nonsmall-cell lung cancer.

    abstract::The incidence of lung cancer continues to rise. The need and demand for more effective treatment to improve survival and palliate symptoms increases at a great rate. The most recent evidence for the use of chemotherapy in the palliative setting is summarized in this review of the literature from the last few years. It...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/00001622-200207000-00002

    authors: Medley L,Cullen M

    更新日期:2002-07-01 00:00:00

  • Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment.

    abstract:PURPOSE OF REVIEW:Primary thyroid lymphoma (PTL) is a rare but clinically important malignancy of the thyroid. This article reviews the diagnosis, histologic subtypes, pathogenesis, and treatment of PTL, with the objective of optimizing diagnosis and management of the disease. RECENT FINDINGS:Recent studies have shed ...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e3283330848

    authors: Graff-Baker A,Sosa JA,Roman SA

    更新日期:2010-01-01 00:00:00

  • Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients.

    abstract:PURPOSE OF REVIEW:Chemotherapy is a cornerstone treatment in patients with early breast cancer. Although some cancer cell-related predictors are emerging, the indications of chemotherapy and the choice of chemotherapy regimen are not individualized enough, emphasizing the need for new predictors. This review will summa...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0b013e32833fb384

    authors: Andre F,Berrada N,Desmedt C

    更新日期:2010-11-01 00:00:00

  • Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma.

    abstract:PURPOSE OF REVIEW:Melanoma has proven resistant to most available chemotherapy and immunotherapy. Despite a range of different biochemical targets, most agents kill cancer cells by induction of apoptosis. RECENT FINDINGS:Investigation of this process has provided insights into the resistance mechanisms in cancer cells...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/01.cco.0000208794.24228.9f

    authors: Hersey P

    更新日期:2006-03-01 00:00:00

  • Testicular cancer.

    abstract::In testicular cancer epidemiology, the increasing recognition that germinal epithelial atrophy is the final common pathway in the development of this tumor has developed along with reports that elevated follicule-stimulating hormone levels at the time of diagnosis of first tumor correlate with risk of developing a sec...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Oliver RT

    更新日期:1991-06-01 00:00:00

  • Advances in the treatment of elderly and frail patients with acute myeloid leukemia.

    abstract:PURPOSE OF REVIEW:Significant advances have been made in the treatment of younger patients with acute myeloid leukemia over the past 3 decades, but prognosis in the elderly has remained dismal, with median survival times of only a few months. Although a small percentage of older patients may be cured by standard chemot...

    journal_title:Current opinion in oncology

    pub_type: 杂志文章,评审

    doi:10.1097/CCO.0000000000000124

    authors: Amadori S,Del Principe MI,Venditti A

    更新日期:2014-11-01 00:00:00